Cargando…

Correction to: Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study

Detalles Bibliográficos
Autores principales:	Beeharry, Maneesh Kumarsing, Zhu, Zheng-Lun, Liu, Wen-Tao, Yao, Xue-Xin, Yan, Min, Zhu, Zheng-Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936063/ https://www.ncbi.nlm.nih.gov/pubmed/31888546 http://dx.doi.org/10.1186/s12885-019-6411-9

Ejemplares similares

Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study
por: Beeharry, Maneesh Kumarsing, et al.
Publicado: (2019)

Optimization of perioperative approaches for advanced and late stages of gastric cancer: clinical proposal based on literature evidence, personal experience, and ongoing trials and research
por: Beeharry, Maneesh Kumarsing, et al.
Publicado: (2020)

Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon II trial
por: Beeharry, Maneesh Kumarsing, et al.
Publicado: (2020)

Preoperative imaging evaluation of the absolute indication criteria for endoscopic submucosal dissection in early gastric cancer patients
por: Shi, Hong-peng, et al.
Publicado: (2020)

Long Noncoding RNA SNHG12 Promotes Gastric Cancer Proliferation by Binding to HuR and Stabilizing YWHAZ Expression Through the AKT/GSK-3β Pathway
por: Zhang, Tianqi, et al.
Publicado: (2021)

YY1-modulated long non-coding RNA SNHG12 promotes gastric cancer metastasis by activating the miR-218-5p/YWHAZ axis
por: Zhang, Tianqi, et al.
Publicado: (2021)

Management of recurrent cervical cancer with peritoneal carcinomatosis with HIPEC
por: Lantsman, Taliya, et al.
Publicado: (2021)

Conversion Surgery with HIPEC for Peritoneal Oli-gometastatic Gastric Cancer
por: Mielko, Jerzy, et al.
Publicado: (2019)

Current role for cytoreduction and HIPEC for gastric cancer with peritoneal disease
por: Khan, Hamza, et al.
Publicado: (2022)

Preoperative Chemotherapy for Gastric Cancer: Personal Interventions and Precision Medicine
por: Xu, Wei, et al.
Publicado: (2016)

Prophylactic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer—A Systematic Review
por: Brenkman, H. J. F., et al.
Publicado: (2019)

The Role of Prophylactic and Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Prevention of Peritoneal Metastases in Advanced Colorectal Cancer
por: Sun, Beatrice J., et al.
Publicado: (2023)

Effect of HIPEC on Peritoneal Recurrence in Peritoneal Metastasis Treated With Cytoreductive Surgery: A Systematic Review
por: Yap, Daniel Ren Yi, et al.
Publicado: (2021)

HIPEC in Peritoneal Metastasis of Gastric Origin: A Systematic Review of Regimens and Techniques
por: Gronau, Felix, et al.
Publicado: (2022)

Role of prophylactic HIPEC in non-metastatic, serosa-invasive gastric cancer: a literature review
por: Kunte, Aditya R., et al.
Publicado: (2022)

Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis in the Elderly
por: Spiliotis, J. D., et al.
Publicado: (2014)

Survival outcomes and prognostic indicators for gastric cancer patients with positive peritoneal wash cytology but no peritoneal metastasis after radical gastrectomy
por: Kang, Wen-Zhe, et al.
Publicado: (2021)

Time to local recurrence as a predictor of survival in unrecetable gastric cancer patients after radical gastrectomy
por: Li, Hui, et al.
Publicado: (2017)

Prevention of Peritoneal Metastases from Colon Cancer in High-Risk Patients: Preliminary Results of Surgery plus Prophylactic HIPEC
por: Sammartino, Paolo, et al.
Publicado: (2012)

Prophylactic HIPEC in pT4 Colon Tumors: Proactive Approach or Overtreatment?
por: Arrizabalaga, Nerea Borda, et al.
Publicado: (2019)

Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer
por: Shepard, Benjamin, et al.
Publicado: (2016)

Cytoreduction and HIPEC in the treatment of “unconventional” secondary peritoneal carcinomatosis
por: Cardi, Maurizio, et al.
Publicado: (2015)

Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis
por: Vassos, Nikolaos, et al.
Publicado: (2016)

Risk Assessment and Preventive Treatment for Peritoneal Recurrence Following Radical Resection for Gastric Cancer
por: Xiang, Lin, et al.
Publicado: (2022)

Cytoreductive surgery and HIPEC in a 14 years old patient with peritoneal recurrence of adenocarcinoma of the right colon
por: Sorrentino, Lorena, et al.
Publicado: (2019)

Bidirectional chemotherapy allowing surgery and HIPEC for malignant peritoneal mesothelioma
por: Noiret, Barbara, et al.
Publicado: (2019)

Prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) for the prevention and control of peritoneal metastasis in patients with gastrointestinal malignancies: a systematic review of randomized controlled trials
por: Dominic, Jerry Lorren, et al.
Publicado: (2021)

Survival of large volume recurrent endometrial cancer with peritoneal metastases treated by cytoreductive surgery, HIPEC and EPIC. Report of a case
por: Sugarbaker, Paul H.
Publicado: (2021)

Neoadjuvant intraperitoneal chemotherapy followed by radical surgery and HIPEC in patients with very advanced gastric cancer and peritoneal metastases: report of an initial experience in a western single center
por: Fava, Bianca Escorel Costa, et al.
Publicado: (2018)

Prophylactic Laparoscopic-Assisted Total Gastrectomy for Hereditary Diffuse Gastric Cancer
por: Francis, Wesley P., et al.
Publicado: (2007)

Limitations of laparoscopy to assess the peritoneal cancer index and eligibility for cytoreductive surgery with HIPEC in peritoneal metastasis
por: Yurttas, Can, et al.
Publicado: (2022)

Immune profile of patients with peritoneal carcinomatosis selected for CRS-HIPEC therapy
por: Kleber, Julia, et al.
Publicado: (2023)

Effective Strategies to Predict Survival of Colorectal Peritoneal Metastases Patients Eligible for Cytoreductive Surgery and HIPEC
por: Simkens, Geert A, et al.
Publicado: (2021)

Treatment of hypermyoglobinemia after CRS + HIPEC for patients with peritoneal carcinomatosis: A retrospective comparative study
por: Liu, Gang, et al.
Publicado: (2017)

The Value of Palliative Gastrectomy for Gastric Cancer Patients With Intraoperatively Proven Peritoneal Seeding
por: Yang, Kun, et al.
Publicado: (2015)

2022 Peritoneal Surface Oncology Group International Consensus on HIPEC Regimens for Peritoneal Malignancies: Colorectal Cancer
por: Hübner, Martin, et al.
Publicado: (2023)

Very early-onset peritoneal recurrence following curative total gastrectomy for Borrmann 4 gastric cancer
por: Kim, Dong Jin, et al.
Publicado: (2014)

Observational Study of Peritoneal Washing Cytology-Positive Gastric Cancer without Gross Peritoneal Metastasis in Patients who Underwent Radical D2 Gastrectomy
por: Shim, Hyun-Jeong, et al.
Publicado: (2020)

Feasibility of totally laparoscopic gastrectomy without prophylactic drains in gastric cancer patients
por: Liu, Hao, et al.
Publicado: (2021)

Management of Inguinal Involvement of Peritoneal Surface Malignancies by Cytoreduction and HIPEC with Inguinal Perfusion
por: Shachar, Yair, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ljnadu93tkdknqmrjouoa2g1rn